Viridian Therapeutics, Inc. (VRDN)
NASDAQ: VRDN · Real-Time Price · USD
28.64
+0.05 (0.17%)
Nov 19, 2025, 12:55 PM EST - Market open

Revenue by Product

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202015 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Monoclonal Antibody
302.00K
Log In
Log In
Log In
Log In
Upgrade
Monoclonal Antibody Growth
-3.82%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202015 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
United States
302.00K
Log In
Log In
Log In
Log In
Upgrade
United States Growth
-3.82%
Log In
Log In
Log In
Log In
Upgrade